Please Wait.....
Report
Germany Cardiovascular Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-07-01 I 80 Pages I Mordor Intelligence
Germany Cardiovascular Devices Market Analysis
The Germany cardiovascular devices market size is USD 3.76 billion in 2024 and is forecast to expand at a 7.39% CAGR to reach USD 5.81 billion by 2030. Higher procedure volumes, an aging population, and expanding remote-monitoring mandates anchor long-term demand. Hospitals continue to invest in structural-heart and rhythm-management systems as DRG payments favor catheter-based interventions over conservative therapy. At the same time, mandatory telemonitoring of chronic heart-failure patients generates recurring revenue for implantable loop recorders and cloud analytics, turning the Germany cardiovascular devices market into a data-driven services arena. EU-MDR compliance costs eliminate many low-margin SKUs, shifting innovation toward AI-enabled diagnostics, minimally invasive systems, and fully implantable pumps that shorten inpatient stays. Although pharmacological advances temper device uptake in early-stage disease, Germany's super-aged demographic keeps replacement and upgrade cycles brisk, sustaining a predictable mid-single-digit revenue trajectory through 2030.
Germany Cardiovascular Devices Market Trends and Insights
Rapid Expansion of Reimbursed Cardiovascular Procedures
Germany's DRG system rewards hospitals for interventional care, lifting procedure counts for transcatheter aortic valve implantation beyond 100,000 cumulative cases. Catheter laboratories continue to replace surgical suites, and reimbursement parity between valve surgery and TAVI compresses payback periods for capital equipment. As 95% of octogenarian patients now receive TAVI, device makers bundle valves with embolic-protection filters to enlarge average selling prices while helping hospitals meet stroke-reduction quality metrics
Mandatory Remote Heart-Failure Telemonitoring
Since 2023, statutory insurers must cover remote telemetry for chronic heart-failure patients, motivating adoption of implantable loop recorders and non-invasive hemodynamic sensors. University centers have established command hubs that analyze continuous data feeds and trigger early outpatient interventions, cutting readmissions and freeing inpatient beds. Vendors offer subscription packages that integrate hardware, analytics dashboards, and reimbursement coding support, encouraging hospitals to migrate from episodic follow-up to always-on monitoring workflows.
EU-MDR Post-Market Costs
The 2021 MDR raised evidence thresholds and introduced intensive post-market surveillance, raising recertification costs by up to 300% for some small firms. With only 43 notified bodies to assess 500,000 devices EU-wide, certification queues stretch into 2026. Many German SMEs drop low-volume catheters rather than fund new trials, consolidating purchasing toward large multinationals and reducing product variety for niche applications.
Other drivers and restraints analyzed in the detailed report include:
Germany's Highest PCI per-Capita Rate Sustains Drug-Eluting-Stent & Guidewire Replacement Cycles / Krankenhaus-Zukunft Act Spurs Digital ICU/OR Hemodynamic-Monitoring Upgrades / Pharmacotherapy Advances Moderating Device Demand /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Therapeutic and Surgical Devices captured 69.20% Germany cardiovascular devices market share in 2024, boosted by 164 TAVI cases per million residents. Growing reliance on drug-eluting stents, left-atrial appendage occluders, and VADs underscores hospitals' preference for minimally invasive solutions that shorten intensive-care occupancy. Despite the maturity of percutaneous coronary intervention, high-risk subsets such as calcified lesions sustain demand for lithotripsy catheters reimbursed under new OPS codes.
Diagnostic and Monitoring Devices, although smaller, will expand at 6.33% CAGR to 2030, buoyed by AI-driven ECG analytics and mandatory heart-failure telemonitoring.
The Germany Cardiovascular Devices Market Report Segments the Industry Into by Device Type (Diagnostic and Monitoring Devices [Electrocardiogram (ECG), Remote Cardiac Monitoring, Other Diagnostic and Monitoring Devices], Therapeutic and Surgical Devices [Cardiac Assist Devices, Cardiac Rhythm Management Device, Catheter, Grafts, Heart Valves, Stents, Other Therapeutic and Surgical Devices]).
List of Companies Covered in this Report:
Medtronic / Abbott Laboratories / Boston Scientific / BIOTRONIK / B. Braun / Edwards Lifesciences Corp. / Siemens Healthineers / GE HealthCare Technologies Inc. / Koninklijke Philips / Terumo Corp. / LivaNova / Getinge AB (Maquet Cardiopulmonary) / Zoll Medical Corp. / Schiller / Dragerwerk / Straub Medical / Lepu Medical / CardioFocus Inc. / MicroPort Scientific Corp. / W. L. Gore & Associates /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rapid Expansion of Reimbursed TAVI & TMVR Procedures Boosting Transcatheter Heart Valve Demand
4.2.2 Mandatory Remote Heart-Failure Telemonitoring (G-BA 2022) Accelerating Implantable Loop Recorder Uptake
4.2.3 Germany's Highest PCI per-Capita in EU Sustaining DES & Guidewire Replacement Cycles
4.2.4 Super-Aged Demographics in Southern & Eastern States Driving Pacemaker & VAD Implant Volumes
4.2.5 R&D Tax Incentives & MDR Transition Supporting Domestic Innovators (e.g., BIOTRONIK)
4.2.6 Krankenhaus-Zukunft Act Funding Digital ICU / OR Hemodynamic Monitoring Systems
4.3 Market Restraints
4.3.1 EU-MDR Post-Market Costs Forcing SMEs to Withdraw Legacy Cardiovascular SKUs
4.3.2 DRG Budget Caps Curbing Ventricular Assist Device Implant Adoption Beyond University Centers
4.3.3 Value-Based Procurement Driving Price Erosion in Stents & Balloons
4.3.4 Pharmacotherapy Advances (e.g., SGLT2i) Moderating Device Therapy Volumes
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Outlook
4.6 Technological Outlook
4.7 Porter's Five Forces
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Suppliers
4.7.3 Bargaining Power of Buyers
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value)
5.1 Diagnostic & Monitoring Devices
5.1.1 ECG Systems
5.1.2 Remote Cardiac Monitor
5.1.3 Cardiac MRI
5.1.4 Cardiac CT
5.1.5 Echocardiography / Ultrasound
5.1.6 Fractional Flow Reserve (FFR) Systems
5.2 Therapeutic & Surgical Devices
5.2.1 Coronary Stents
5.2.1.1 Drug-Eluting Stents
5.2.1.2 Bare-Metal Stents
5.2.1.3 Bioresorbable Stents
5.2.2 Catheters
5.2.2.1 PTCA Balloon Catheters
5.2.2.2 IVUS/OCT Catheters
5.2.3 Cardiac Rhythm Management
5.2.3.1 Pacemakers
5.2.3.2 Implantable Cardioverter Defibrillators
5.2.3.3 Cardiac Resynchronization Therapy Devices
5.2.4 Heart Valves
5.2.4.1 TAVR/TAVI
5.2.4.2 Mechanical Valves
5.2.4.3 Tissue/Bioprosthetic Valves
5.2.5 Ventricular Assist Devices
5.2.6 Artificial Hearts
5.2.7 Grafts & Patches
5.2.8 Other Cardiovascular Surgical Devices
5.3 By Application
5.3.1 Coronary Artery Disease
5.3.2 Arrhythmia
5.3.3 Heart Failure
5.3.4 Structural Heart Disease
5.3.5 Hypertension
5.3.6 Others
5.4 By End user
5.4.1 Hospitals
5.4.2 Home-Care Settings
5.4.3 Others
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
6.3.1 Medtronic plc
6.3.2 Abbott Laboratories
6.3.3 Boston Scientific Corporation
6.3.4 BIOTRONIK SE & Co. KG
6.3.5 B. Braun Melsungen AG
6.3.6 Edwards Lifesciences Corp.
6.3.7 Siemens Healthineers AG
6.3.8 GE HealthCare Technologies Inc.
6.3.9 Philips Healthcare
6.3.10 Terumo Corp.
6.3.11 LivaNova PLC
6.3.12 Getinge AB (Maquet Cardiopulmonary)
6.3.13 Zoll Medical Corp.
6.3.14 Schiller AG
6.3.15 Dragerwerk AG & Co. KGaA
6.3.16 Straub Medical AG
6.3.17 Lepu Medical Technology
6.3.18 CardioFocus Inc.
6.3.19 MicroPort Scientific Corp.
6.3.20 W. L. Gore & Associates Inc.
7 Market Opportunities & Future Outlook
7.1 White-Space & Unmet-Need Assessment
8 G. Regional Growth Rates (Not Applicable)
9 Final TOC does not include continent-level geographic segmentation; hence no regional growth-rate table is required under guideline G.
10 .......
11 New Research
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security